Ultraflitration of wastewater with pretreatment: evaluation of flux decline models

Three different mathematical models relating the flux decline were investigated to quantify the effects of pretreatment in a membrane filtration system. The models used are empirical flux decline model, series resistance flux decline model and modified series resistance flux decline model. A cross flow ultrafiltration unit was used to study flux decline and organic removal from synthetic wastewater. Flocculation and adsorption pretreatments were carried out with ferric chloride (FeCl3) and activated carbon of different doses. The three models could predict flux decline after different pretreatments and could be used as a pretreatment index to ultrafiltration. © 2008

Adsorption characteristics of acetaldehyde on activated carbons prepared from corn-based biomass precursor

The ACs (R-1/2 and R-1/4) having two different textual and chemical properties are prepared from corn-based biomass precursor and evaluated together with a wood-based activated carbon (WAC) at room temperature using a gas chromatograph. The results obtained from the correlation studies indicate that the pore size distribution (below 8Å) and the relatively lower energetic heterogeneity of ACs on acetaldehyde adsorption are considerable factors rather than that of a specific surface area and surface chemistry. The adsorption equilibrium of ACs is well correlated with the Sips equation. The pseudo second-order equation was better in describing the ACs' adsorption kinetic of acetaldehyde. © Taylor & Francis Group, LLC

Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation

The chemotherapeutic use of cisplatin is limited by its severe side effects. In this study, by conducting different omics data analyses, we demonstrated that cisplatin induces cell death in a proximal tubular cell line by suppressing glycolysis-and tricarboxylic acid (TCA)/mitochondria-related genes. Furthermore, analysis of the urine from cisplatin-treated rats revealed the lower expression levels of enzymes involved in glycolysis, TCA cycle, and genes related to mitochondrial stability and confirmed the cisplatin-related metabolic abnormalities. Additionally, an increase in the level of p53, which directly inhibits glycolysis, has been observed. Inhibition of p53 restored glycolysis and significantly reduced the rate of cell death at 24 h and 48 h due to p53 inhibition. The foremost reason of cisplatin-related cytotoxicity has been correlated to the generation of mitochondrial reactive oxygen species (ROS) that influence multiple pathways. Abnormalities in these pathways resulted in the collapse of mitochondrial energy production, which in turn sensitized the cells to death. The quenching of ROS led to the amelioration of the affected pathways. Considering these observations, it can be concluded that there is a significant correlation between cisplatin and metabolic dysfunctions involving mROS as the major player.116224Ysciescopu

W5ater desalination using graphene-enhanced electrospun nanofiber membrane via air gap membrane distillation

© 2016 This study demonstrates the preparation and desalination performance via air gap membrane distillation (AGMD) of a graphene-loaded electrospun nanofiber membrane. Different concentrations of graphene (0–10 wt%) were incorporated in/on electrospun polyvinylidene fluoride-co-hexafluoropropylene (PH) membrane to obtain a robust, and superhydrophobic nanocomposite membrane. The results showed that graphene incorporation has significantly enhanced the membrane structure and properties with an optimal concentration of 5 wt% (i.e., G5PH). Characterization of G5PH revealed membrane porosity of >88%, contact angle of >162° (superhydrophobic), and high liquid entry pressure (LEP) of >186 kPa. These favourable properties led to a high and stable AGMD flux of 22.9 L/m2 h or LMH (compared with ~4.8 LMH for the commercial PVDF flat-sheet membrane) and excellent salt rejection (100%) for 60 h of operation using 3.5 wt% NaCl solution as feed (feed and coolant inlet temperatures of 60 and 20 °C, respectively). A two-dimensional dynamic model to investigate the flux profile of the graphene/PH membrane is also introduced. The present study suggests that exploiting the interesting properties of nanofibers and graphene nanofillers through a facile electrospinning technique provides high potential towards the fabrication of a robust and high-performance AGMD membrane

Graphene/PVDF flat-sheet membrane for the treatment of RO brine from coal seam gas produced water by air gap membrane distillation

© 2016 Elsevier B.V. Brine management of coal seam gas (CSG) produced water is a significant concern for the sustainable production of CSG in Australia. Membrane distillation (MD) has shown the potential to further reduce the volume of CSG reverse osmosis (RO) brine. However, despite its potential, the lack of appropriate MD membranes limits its industrial use. Therefore, this study was aimed on the fabrication of a robust membrane for the treatment of real RO brine from CSG produced water via an air gap MD (AGMD) process. Here, graphene/polyvinylidene fluoride (G/PVDF) membranes at various graphene loadings 0.1-2.0 wt% w.r.t. to PVDF) were prepared through a phase inversion method. Surface characterization revealed that all G/PVDF membranes exhibited favorable membrane properties having high porosity (>78%), suitable mean pore size (3.66 bar). AGMD test results (feed inlet: 60.0±1.5 °C; coolant inlet: 20.0±1.5 °C) for 24 h operation indicated a high water vapor flux and salt rejection of 20.5 L/m2h and 99.99%, respectively for the optimal graphene loading of 0.5 wt%, i.e., G/PVDF-0.5 membrane (compared to 11.6 L/m2h and 99.96% for neat PVDF membrane). Long-term AGMD operation of 10 days further revealed the robustness of G/PVDF membrane with superior performance compared to commercial PVDF membrane (85.3% final normalized flux/99.99% salt rejection against 51.4%/99.95% for commercial membrane). Incorporation of graphene has resulted to improved wetting resistance and more robust membrane that has the potential for the treatment of RO brine from CSG produced water via AGMD

Isolation and Characterization of EstC, a New Cold-Active Esterase from Streptomyces coelicolor A3(2)

The genome sequence of Streptomyces coelicolor A3(2) contains more than 50 genes coding for putative lipolytic enzymes. Many studies have shown the capacity of this actinomycete to store important reserves of intracellular triacylglycerols in nutrient depletion situations. In the present study, we used genome mining of S. coelicolor to identify genes coding for putative, non-secreted esterases/lipases. Two genes were cloned and successfully overexpressed in E. coli as His-tagged fusion proteins. One of the recombinant enzymes, EstC, showed interesting cold-active esterase activity with a strong potential for the production of valuable esters. The purified enzyme displayed optimal activity at 35°C and was cold-active with retention of 25% relative activity at 10°C. Its optimal pH was 8.5–9 but the enzyme kept more than 75% of its maximal activity between pH 7.5 and 10. EstC also showed remarkable tolerance over a wide range of pH values, retaining almost full residual activity between pH 6–11. The enzyme was active toward short-chain p-nitrophenyl esters (C2–C12), displaying optimal activity with the valerate (C5) ester (kcat/Km = 737±77 s−1 mM−1). The enzyme was also very active toward short chain triglycerides such as triacetin (C2:0) and tributyrin (C4:0), in addition to showing good primary alcohol and organic solvent tolerance, suggesting it could function as an interesting candidate for organic synthesis of short-chain esters such as flavors

Cks1 Is Required for Tumor Cell Proliferation but Not Sufficient to Induce Hematopoietic Malignancies

The Cks1 component of the SCFSkp2 complex is necessary for p27Kip1 ubiquitylation and degradation. Cks1 expression is elevated in various B cell malignancies including Burkitt lymphoma and multiple myeloma. We have previously shown that loss of Cks1 results in elevated p27Kip1 levels and delayed tumor development in a mouse model of Myc-induced B cell lymphoma. Surprisingly, loss of Skp2 in the same mouse model also resulted in elevated p27Kip1 levels but exhibited no impact on tumor onset. This raises the possibility that Cks1 could have other oncogenic activities than suppressing p27Kip1. To challenge this notion we have targeted overexpression of Cks1 to B cells using a conditional retroviral bone marrow transduction-transplantation system. Despite potent ectopic overexpression, Cks1 was unable to promote B cell hyperproliferation or B cell malignancies, indicating that Cks1 is not oncogenic when overexpressed in B cells. Since Skp2 overexpression can drive T-cell tumorigenesis or other cancers we also widened the quest for oncogenic activity of Cks1 by ubiquitously expressing Cks1 in hematopoetic progenitors. At variance with c-Myc overexpression, which caused acute myeloid leukemia, Cks1 overexpression did not induce myeloproliferation or leukemia. Therefore, despite being associated with a poor prognosis in various malignancies, sole Cks1 expression is insufficient to induce lymphoma or a myeloproliferative disease in vivo

Discovery of a Novel hsp65 Genotype within Mycobacterium massiliense Associated with the Rough Colony Morphology

So far, genetic diversity among strains within Mycobacterium massiliense has rarely been studied. To investigate the genetic diversity among M. massiliense, we conducted phylogenetic analysis based on hsp65 (603-bp) and rpoB (711-bp) sequences from 65 M. massiliense Korean isolates. We found that hsp65 sequence analysis could clearly differentiate them into two distinct genotypes, Type I and Type II, which were isolated from 35 (53.8%) and 30 patients (46.2%), respectively. The rpoB sequence analysis revealed a total of four genotypes (R-I to R-IV) within M. massiliense strains, three of which (R-I, R-II and R-III) correlated with hsp65 Type I, and other (R-IV), which correlated with Type II. Interestingly, genotyping by the hsp65 method agreed well with colony morphology. Despite some exceptions, Type I and II correlated with smooth and rough colonies, respectively. Also, both types were completely different from one another in terms of MALDI-TOF mass spectrometry profiles of whole lipid. In addition, we developed PCR-restriction analysis (PRA) based on the Hinf I digestion of 644-bp hsp65 PCR amplicons, which enables the two genotypes within M. massiliense to be easily and reliably separated. In conclusion, two distinct hsp65 genotypes exist within M. massiliense strains, which differ from one another in terms of both morphology and lipid profile. Furthermore, our data indicates that Type II is a novel M. massiliense genotype being herein presented for the first time. The disparity in clinical traits between these two hsp65 genotypes needs to be exploited in the future study

Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells

<p>Abstract</p> <p>Background</p> <p>The cyclin-dependent kinase (CDK) inhibitor p27^Kip1is downregulated in a majority of human cancers due to ectopic proteolysis by the ubiquitin-proteasome pathway. The expression of p27 is subject to multiple mechanisms of control involving several transcription factors, kinase pathways and at least three different ubiquitin ligases (SCF^SKP2, KPC, Pirh2), which regulate p27 transcription, translation, protein stability and subcellular localization. Using a chemical genetics approach, we have asked whether this control network can be modulated by small molecules such that p27 protein expression is restored in cancer cells.</p> <p>Results</p> <p>We developed a cell-based assay for measuring the levels of endogenous nuclear p27 in a high throughput screening format employing LNCaP prostate cancer cells engineered to overexpress SKP2. The assay platform was optimized to Z' factors of 0.48 - 0.6 and piloted by screening a total of 7368 chemical compounds. During the course of this work, we discovered two small molecules of previously unknown biological activity, SMIP001 and SMIP004, which increase the nuclear level of p27 at low micromolar concentrations. SMIPs (small molecule inhibitors of p27 depletion) also upregulate p21^Cip1, inhibit cellular CDK2 activity, induce G1 delay, inhibit colony formation in soft agar and exhibit preferential cytotoxicity in LNCaP cells relative to normal human fibroblasts. Unlike SMIP001, SMIP004 was found to downregulate SKP2 and to stabilize p27, although neither SMIP is a proteasome inhibitor. Whereas the screening endpoint - nuclear p27 - was robustly modulated by the compounds, SMIP-mediated cell cycle arrest and apoptosis were not strictly dependent on p27 and p21 - a finding that is explained by parallel inhibitory effects of SMIPs on positive cell cycle regulators, including cyclins E and A, and CDK4.</p> <p>Conclusions</p> <p>Our data provide proof-of-principle that the screening platform we developed, using endogenous nuclear p27 as an endpoint, presents an effective means of identifying bioactive molecules with cancer selective antiproliferative activity. This approach, when applied to larger and more diverse sets of compounds with refined drug-like properties, bears the potential of revealing both unknown cellular pathways globally impinging on p27 and novel leads for chemotherapeutics targeting a prominent molecular defect of human cancers.</p